<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240503061635N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-14</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of treatment with Cerebrum electrical stimulation on tinnitus patients with normal hearing sensitivity</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of treatment with Cerebrum electrical stimulation on tinnitus patients with normal hearing sensitivity: A Randomized Clinical trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/76655</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients with qualified criteria will be divided into two groups using random block design. Online website (https://www.seaaledenvelope.com) is used to generate a random list based on the desired sample size and block size 4. After creating a list, each patient will be identified with a unique code during the study. 20 people are selected for the intervention group and 20 are selected for the Sham Group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Tinnitus - the beauty of hearing.</hc_freetext>
      <i_freetext>Intervention 1: Each group will have 20 patients. The patients of the treatment group received transcortical direct current radiation protocol (tDCS) in the form of a current of 2 mA, a duration of 20 minutes, the anode electrode was placed on the auditory cortex of the left hemisphere (T3) and the cathode electrode was applied on the auditory cortex of the right hemisphere (T4). Placement of the current electrode is performed using the standard electrode placement of 10-20 EEG. of 35 cm2 square carbon electrodes moistened with 0.9% saline solution to create the desired conductivity for generating current. Irradiation is done once a day for 10 days (Oasis Pro device). The primary therapeutic index is the loudness of the tinnitus and the patient's annoyance caused by the tinnitus. The loudness of the voice is evaluated by the VAS questionnaire, which is determined using a numerical scale of 0 to 10, and the larger values ​​indicate the greater intensity of the loudness of the buzzing sound. The degree of annoyance of the patient caused by tinnitus is evaluated by the THI questionnaire, which consists of 25 questions and each question is answered as yes/no and sometimes, and scores of 4, 0, and 2 are given to each answer, respectively. Scores between 0-100 are obtained and higher values ​​indicate higher intensity of irritation caused by tinnitus. The loudness of tinnitus and its annoyance are measured before the beginning of the treatment sessions and one week and two weeks after the end of the treatment sessions and are compared for each patient. Also, the difference between these values ​​between the active treatment group and the placebo group (sham control) is also compared. Intervention 2: Control group: Control group: In the patients of the control group, the electrode is connected, but no electrical stimulation is applied and it only has a psychological aspect.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nader saki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The Jundishapur University of Medical Sciences is located in the cJundishapur University of Medical Sciences Golestan Boulevard, University City Ahvaz, Khuzestan Province Iran</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15794- 61357a</zip>
        <telephone>+98 61 3314 0000</telephone>
        <email>saki-n@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nader saki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>اهواز ، بلوار علوم پزشکی ،  علوم پزشکی جندی شاپور</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135715794</zip>
        <telephone>+98 61 3314 0000</telephone>
        <email>saki-n@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with tinnitus and natural hearing sensitivity are selected by ENT specialists and authentic evaluations by ENT specialists and diagnosed chronic tinnitus problems for this study.
Patients with idiopathic tinnitus who have not responded to drug treatments are selected for this program.
The age range is from 20 to 70 years.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Cardiovascular patients
pregnant women
Brain patients
History of brain surgery
People with metal or electronic implants
People with a history of mental illness
psychological
People with a history of alcohol and drug abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H93.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Tinnitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Each group will have 20 patients. The patients of the treatment group received transcortical direct current radiation protocol (tDCS) in the form of a current of 2 mA, a duration of 20 minutes, the anode electrode was placed on the auditory cortex of the left hemisphere (T3) and the cathode electrode was applied on the auditory cortex of the right hemisphere (T4). Placement of the current electrode is performed using the standard electrode placement of 10-20 EEG. of 35 cm2 square carbon electrodes moistened with 0.9% saline solution to create the desired conductivity for generating current. Irradiation is done once a day for 10 days (Oasis Pro device). The primary therapeutic index is the loudness of the tinnitus and the patient's annoyance caused by the tinnitus. The loudness of the voice is evaluated by the VAS questionnaire, which is determined using a numerical scale of 0 to 10, and the larger values ​​indicate the greater intensity of the loudness of the buzzing sound. The degree of annoyance of the patient caused by tinnitus is evaluated by the THI questionnaire, which consists of 25 questions and each question is answered as yes/no and sometimes, and scores of 4, 0, and 2 are given to each answer, respectively. Scores between 0-100 are obtained and higher values ​​indicate higher intensity of irritation caused by tinnitus. The loudness of tinnitus and its annoyance are measured before the beginning of the treatment sessions and one week and two weeks after the end of the treatment sessions and are compared for each patient. Also, the difference between these values ​​between the active treatment group and the placebo group (sham control) is also compared.</i_keyword>
      <i_keyword>Control group: Control group: In the patients of the control group, the electrode is connected, but no electrical stimulation is applied and it only has a psychological aspect.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Loudness level of tinnitus. Timepoint: 10 DAYS. Method of measurement: Transcortical direct current (tDCS) irradiation at a current of 2 mA.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The degree of patient annoyance caused by tinnitus by THI questionnaire. Timepoint: 10 DAYS. Method of measurement: THI questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Jundishapur University of Ahvaz</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-07-02</approval_date>
        <contact_name>Ethics Committee of Jundishapur University of Medical Sciences</contact_name>
        <contact_address>Iran - Ahvaz - Golestan Boulevard - Jundishapur University Ahwaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
